Cytokinetics (CYTK) Enterprise Value (2010 - 2026)
Cytokinetics (CYTK) recorded Enterprise Value of $10.68 billion in Q2 2026, up 245.1% from $3.09 billion a year earlier and up 44.6% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Enterprise Value (2010 - 2026) Analysis & Trends
On a TTM basis, Cytokinetics' Enterprise Value came in at $8.01 billion as of Jun 30, 2026; for FY2025, it came in at $6.93 billion, up 54.5% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of 46.9% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $4.48 billion in FY2024 (-43.0%), $7.87 billion in FY2023 (+121.0%), $3.56 billion in FY2022 (+4.9%) and $3.39 billion in FY2021 (+235.4%).
- The Q2 2026 figure is the highest quarterly Enterprise Value in data going back to Q4 2010.
- On a year-over-year basis, Enterprise Value has increased for four consecutive quarters, with growth averaging 50.2% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 245.1% in Q2 2026, against a decline of 43.0% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $7.38 billion (Q1 2026), $6.93 billion (Q4 2025) and $5.76 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Cytokinetics | 9.20 Bn | 5.37 Bn | 25.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.68 Bn |
| Mar 31, 2026 | 7.38 Bn |
| Dec 31, 2025 | 6.93 Bn |
| Sep 30, 2025 | 5.76 Bn |
| Jun 30, 2025 | 3.09 Bn |
| Mar 31, 2025 | 3.86 Bn |
| Dec 31, 2024 | 4.48 Bn |
| Sep 30, 2024 | 5.22 Bn |
| Jun 30, 2024 | 5.32 Bn |
| Mar 31, 2024 | 6.73 Bn |
| Dec 31, 2023 | 7.87 Bn |
| Sep 30, 2023 | 2.29 Bn |
| Jun 30, 2023 | 2.57 Bn |
| Mar 31, 2023 | 2.70 Bn |
| Dec 31, 2022 | 3.56 Bn |
| Sep 30, 2022 | 3.72 Bn |
| Jun 30, 2022 | 3.11 Bn |
| Mar 31, 2022 | 2.54 Bn |
| Dec 31, 2021 | 3.39 Bn |
| Sep 30, 2021 | 2.52 Bn |
API Access
Cytokinetics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();